IMI Research Published in Women’s Health Issues Journal
Institute for Medicaid InnovationJennifer E. Moore, PhD, RN, FAAN
Pregnant women who have experienced a prior preterm birth are advised to get progesterone injections to prevent another one, but Medicaid coverage of these injections varies between states and managed care organizations. A new study conducted by IMI team members was published in the journal Women’s Health Issues. Our study involved a survey of Medicaid managed care organizations about their coverage policies and procedures for progesterone injections found substantial variations, including differences in prior authorization requirements and the period of pregnancy for which injections were covered. In a companion commentary, Anne Rossier Markus reviews the laws relevant to these coverage policies; her piece can serve as a resource for untangling the policy complexity that can lead to the kinds of coverage variation found. To access all of the resources on this study, the following links are provided:
